| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.5B | $2.6B | $2.7B | $2.2B | $2.2B | — | — | — |
| Cost of Revenue | $1.0B | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.5B | $0.5B | $0.4B | $0.4B | $0.5B | $0.0B | $-0.0B | $-0.0B |
| Net Income | $0.3B | $0.3B | $0.2B | $0.2B | $0.3B | $-0.0B | $-0.0B | $-0.0B |
| EPS (Basic) | $4.39 | $4.20 | $3.86 | $3.96 | $4.97 | $-0.45 | $-0.75 | $-0.51 |
| EPS (Diluted) | $4.37 | $4.19 | $3.85 | $3.95 | $4.96 | $-0.45 | $-0.74 | $-0.51 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.6B | $10.9B | $10.3B | $10.1B | $9.4B | $8.2B | $7.6B | $6.8B |
| Current Assets | $0.8B | $0.8B | $1.1B | $1.6B | $1.3B | $0.6B | $0.6B | $0.7B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $2.5B | $1.7B | $1.8B | $2.4B | $1.6B | $1.4B | $1.5B | $1.3B |
| Stockholders' Equity | $3.4B | $3.2B | $2.9B | $2.8B | $2.7B | $2.5B | $2.5B | $2.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.9B | $0.4B | $0.1B | $0.2B | $0.5B | $0.5B | $0.5B |
| Investing Cash Flow | $-0.9B | $-1.0B | $-0.7B | $-0.5B | $-0.6B | $-0.6B | $-0.8B | $-0.5B |
| Capital Expenditures | $0.9B | $0.9B | $0.7B | $0.6B | $0.6B | $0.6B | $0.8B | $0.5B |
| Financing Cash Flow | $0.3B | $0.1B | $0.3B | $0.5B | $0.4B | $0.2B | $0.4B | $0.1B |